e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An assay based on RD1 selected peptides for the diagnosis of extra-pulmonary and smear negative tuberculosis
S. Carrara, O. Butera, V. Vanini, F. Palmieri, E. Girardi, D. Goletti (Rome, Italy)
Source:
Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Session:
Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Session type:
Oral Presentation
Number:
4584
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Carrara, O. Butera, V. Vanini, F. Palmieri, E. Girardi, D. Goletti (Rome, Italy). An assay based on RD1 selected peptides for the diagnosis of extra-pulmonary and smear negative tuberculosis. Eur Respir J 2008; 32: Suppl. 52, 4584
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Response to
M. tuberculosis
selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005
Performance of RD-1 based blood assays in clinical management of smear-negative pulmonary and extra-pulmonary tuberculosis
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
The quantiferon testing and the diagnosis of tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Diagnosis of smear negative pulmonary tuberculosis (PTB) by pooling two induced sputums on the same day
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
The diagnostic efficiency of TB quantiferon gold test in tuberculosis (preeliminary reports)
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
Utility of MPT64 antigen detection test for diagnosis of HIV coinfected extrapulmonary tuberculosis in Tanzania
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
A new immune diagnostic assay based on ESAT-6 and CFP-10 epitopes in the evaluation of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 427s
Year: 2004
The role of a new immuno-diagnostic test based on ESAT-6 epitopes in the screening of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 166s
Year: 2003
Role of bronchial aspirate samples for the diagnosis of pulmonary tuberculosis in patients with negative smear and negative Xpert MTB/Rif in sputum
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020
Quantiferon–TB Gold test in cases of active pulmonary tuberculosis initially and during treatment
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Infectiousness of tuberculosis patients identified through spot sputum screening compared to patients identified through passive case finding-comparing sputum smear microscopy results
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Bronchoscopy as a diagnostic tool in pulmonary tuberculosis suspects with sputum smear negative status
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007
Treatment outcomes of smear positive pulmonary tuberculosis cases
Source: Eur Respir J 2005; 26: Suppl. 49, 647s
Year: 2005
Cryobiopsy in diagnosis of smear negative pulmonary tuberculosis (SNPTB)
Source: International Congress 2018 – Cryobiopsy in interstitial lung disease (ILD)
Year: 2018
Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
Comparison of BAL ELISPOT and NAT for the diagnosis of smear-negative tuberculosis – a TBNET study
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay
Source: Eur Respir J 2007; 29: 605-607
Year: 2007
Role of AFB stain, Mycobacterium tuberculosisM.TB) culture and TB-PCR in EBUS-TBNA samples for diagnosing TB in an endemic country
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept